Navigation Links
Predicting drug responsiveness in cancer patients
Date:7/26/2010

Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.

Specifically, the team found that human cancer cells with mutations in the PIK3CA gene responded to everolimus in vitro except when a KRAS gene mutation was also present. Importantly, in a cohort of metastatic cancer patients, the presence of KRAS gene mutations was associated with lack of response to treatment with everolimus therapy. These data suggest that by looking for the presence or absence of PIK3CA and KRAS mutations in a person's tumor it will be possible to predict whether or not that person will benefit from treatment with a drug that targets mTOR. However, as noted in an accompanying commentary, by Morassa Mohseni and Ben Ho Park, at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, while these data have enormous potential to change clinical practice, larger prospective studies are required to verify them.


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. MSU scientists develop more effective method of predicting lead-poisoning risk
2. Newer Genetic Info Adds Little to Predicting Breast Cancer
3. Breakthrough in Predicting Invasive Breast Cancer
4. Nasendoscopy proves useful in predicting treatment success in sleep apnea patients
5. Traditional neurologic exams inadequate for predicting survival of cardiac arrest patients
6. Predicting Alzheimers Risk in Patients With Cognitive Problems
7. Enhancing arrest of cell growth to treat cancer in mice
8. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
9. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
10. Low forms of cyclin E reduce breast cancer drugs effectiveness
11. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... ... January 13, 2017 , ... With ... on the challenge of providing additional organic alternatives for customers who have grown ... the brand’s new line of all-natural activated charcoal products, Moody Zook Chief Executive ...
(Date:1/13/2017)... ... 2017 , ... An inventor from Virginia Beach, Va., is always on the ... diversify my outfits, so he decided to design something that enhances the look of ... of a belt to allow for quick, easy changing of its look. This not ...
(Date:1/13/2017)... ... 2017 , ... "We wanted to create a design for orthodontic appliances that ... from Virginia Beach, Va. , They created a prototype for the patent-pending BRACE FACERS ... braces to be customized to suit personal tastes. They can be used to create ...
(Date:1/13/2017)... ... January 13, 2017 , ... On January 11th, Finnleo ... MN, with the official send-off from Orchestra Hall in Minneapolis on Saturday, January ... Orchestra’s Music Director, leading the official launch of the sauna. After leaving Minneapolis, ...
(Date:1/13/2017)... ... January 13, 2017 , ... The Joint Corp. was ... franchise ranking. Recognized by entrepreneurs and franchisors as a top competitive measurement, the ... areas including financial strength and stability, growth rate, and brand power. , “It ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... January 16, 2017 ... Product Type (Methyl, Ethyl, Hydroxyethyl, Hydroxypropyl, Carboxymethyl ... Beverages, Surface Coatings & Paints), Region - ... the market was valued at USD 4.51 ... reach USD 6.41 Billion by 2021, at ...
(Date:1/16/2017)... Bill is an internationally experienced medical device ... leadership positions with global medical device companies, including Smith & Nephew, ... launching new products and building successful businesses in the sector and ... and North America . ... Educated at the University of ...
(Date:1/16/2017)... -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is pleased to announce ... to its Board of Directors. He is the President ... LLC . He is also the Chief Investment Officer ... firm with over $1.5 billion under management. ... analysis and portfolio management. He began his career in ...
Breaking Medicine Technology: